{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:13:22Z","timestamp":1761920002988,"version":"3.44.0"},"reference-count":15,"publisher":"BMJ","content-domain":{"domain":["bmj.com"],"crossmark-restriction":true},"short-container-title":["BMJ Case Reports"],"accepted":{"date-parts":[[2015,6,3]]},"abstract":"<jats:p>We describe the case of a 51-year-old man with recently diagnosed ulcerative colitis who developed fever and elevated liver enzymes as well as cholestasis a few weeks after starting treatment with mesalazine. As no obvious cause was found and fever persisted, liver biopsy was performed and revealed granulomatous hepatitis. The patient recovered completely after cessation of mesalazine, so that a drug-induced granulomatous hepatitis after exclusion of other differential diagnoses in an extensive work up was assumed. The present case demonstrates that even though drug-induced liver injury due to mesalazine is rare, it should be considered in unclear cases and lead to prompt discontinuation of mesalazine.<\/jats:p>","DOI":"10.1136\/bcr-2014-205857","type":"journal-article","created":{"date-parts":[[2015,6,26]],"date-time":"2015-06-26T23:16:12Z","timestamp":1435360572000},"page":"bcr2014205857","update-policy":"https:\/\/doi.org\/10.1136\/crossmarkpolicy","source":"Crossref","is-referenced-by-count":7,"title":["An unusual cause of febrile hepatitis"],"prefix":"10.1136","volume":"2015","author":[{"given":"Teresa","family":"Stelzer","sequence":"first","affiliation":[{"name":"Department of Internal Medicine, Spital Zollikerberg, Zollikerberg, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sibylle","family":"Kohler","sequence":"additional","affiliation":[{"name":"Department of Endocrinology, University Hospital Zurich, Zurich, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ewerton","family":"Marques Maggio","sequence":"additional","affiliation":[{"name":"Department of Pathology, University Hospital Zurich, Zurich, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ludwig Theodor","family":"Heuss","sequence":"additional","affiliation":[{"name":"Department of Internal Medicine, Spital Zollikerberg, Zollikerberg, Switzerland"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"239","published-online":{"date-parts":[[2015,6,25]]},"reference":[{"key":"2025082701461616000_2015.jun25_1.bcr2014205857.1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1478-3231.2008.01695.x"},{"key":"2025082701461616000_2015.jun25_1.bcr2014205857.2","doi-asserted-by":"publisher","DOI":"10.1016\/j.cld.2010.07.005"},{"key":"2025082701461616000_2015.jun25_1.bcr2014205857.3","doi-asserted-by":"publisher","DOI":"10.1016\/j.cld.2012.03.013"},{"key":"2025082701461616000_2015.jun25_1.bcr2014205857.4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/642923","article-title":"Liver disorders in inflammatory bowel disease","volume":"2012","author":"Uko","year":"2012","journal-title":"Gastroenterol Res Pract"},{"key":"2025082701461616000_2015.jun25_1.bcr2014205857.5","doi-asserted-by":"publisher","DOI":"10.3748\/wjg.15.2817"},{"key":"2025082701461616000_2015.jun25_1.bcr2014205857.6","doi-asserted-by":"publisher","DOI":"10.1093\/jac\/dkr159"},{"key":"2025082701461616000_2015.jun25_1.bcr2014205857.7","first-page":"893","article-title":"The role of mesalamine in the treatment of ulcerative colitis","volume":"3","author":"Karagozian","year":"2007","journal-title":"Ther Clin Risk Manag"},{"key":"2025082701461616000_2015.jun25_1.bcr2014205857.8","doi-asserted-by":"publisher","DOI":"10.1136\/gut.51.4.536"},{"key":"2025082701461616000_2015.jun25_1.bcr2014205857.9","doi-asserted-by":"publisher","DOI":"10.1016\/S0168-8278(97)80061-X"},{"key":"2025082701461616000_2015.jun25_1.bcr2014205857.10","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1016\/0016-5085(92)91453-B","article-title":"Hypersensitivity with hepatotoxicity to mesalazine after hypersensitivity to sulfasalazine","volume":"103","author":"Hautekeete","year":"1992","journal-title":"Gastroenterology"},{"key":"2025082701461616000_2015.jun25_1.bcr2014205857.11","doi-asserted-by":"publisher","DOI":"10.1111\/j.1572-0241.1999.01245.x"},{"key":"2025082701461616000_2015.jun25_1.bcr2014205857.12","doi-asserted-by":"publisher","DOI":"10.1097\/00004836-198106000-00017"},{"key":"2025082701461616000_2015.jun25_1.bcr2014205857.13","doi-asserted-by":"publisher","DOI":"10.1097\/00007611-197809000-00031"},{"key":"2025082701461616000_2015.jun25_1.bcr2014205857.14","doi-asserted-by":"publisher","DOI":"10.1186\/1471-230X-1-8"},{"key":"2025082701461616000_2015.jun25_1.bcr2014205857.15","doi-asserted-by":"publisher","DOI":"10.1136\/gut.44.6.886"}],"container-title":["BMJ Case Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/syndication.highwire.org\/content\/doi\/10.1136\/bcr-2014-205857","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,27]],"date-time":"2025-08-27T08:46:25Z","timestamp":1756284385000},"score":1,"resource":{"primary":{"URL":"https:\/\/casereports.bmj.com\/lookup\/doi\/10.1136\/bcr-2014-205857"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,6,25]]},"references-count":15,"alternative-id":["10.1136\/bcr-2014-205857"],"URL":"https:\/\/doi.org\/10.1136\/bcr-2014-205857","relation":{},"ISSN":["1757-790X"],"issn-type":[{"type":"electronic","value":"1757-790X"}],"subject":[],"published":{"date-parts":[[2015,6,25]]}}}